Beijing Konruns PharmaceuticalLtd Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Beijing Konruns PharmaceuticalLtd has a total shareholder equity of CN¥3.5B and total debt of CN¥204.7M, which brings its debt-to-equity ratio to 5.8%. Its total assets and total liabilities are CN¥4.0B and CN¥478.6M respectively. Beijing Konruns PharmaceuticalLtd's EBIT is CN¥81.4M making its interest coverage ratio -4.5. It has cash and short-term investments of CN¥640.3M.
Wichtige Informationen
5.8%
Verhältnis von Schulden zu Eigenkapital
CN¥204.68m
Verschuldung
| Zinsdeckungsgrad | -4.5x |
| Bargeld | CN¥640.32m |
| Eigenkapital | CN¥3.52b |
| Gesamtverbindlichkeiten | CN¥478.64m |
| Gesamtvermögen | CN¥4.00b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 603590's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥319.5M).
Langfristige Verbindlichkeiten: 603590's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥159.2M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 603590 has more cash than its total debt.
Schulden abbauen: 603590's debt to equity ratio has increased from 0% to 5.8% over the past 5 years.
Schuldendeckung: 603590's debt is well covered by operating cash flow (80.5%).
Zinsdeckung: 603590 earns more interest than it pays, so coverage of interest payments is not a concern.